Share on StockTwits

Minerva Neurosciences (NASDAQ:NERV) CEO Coelho Rogerio Vivaldi purchased 41,667 shares of the company’s stock on the open market in a transaction dated Tuesday, July 1st. The shares were purchased at an average price of $6.00 per share, with a total value of $250,002.00. Following the transaction, the chief executive officer now directly owns 41,667 shares in the company, valued at approximately $250,002. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of Minerva Neurosciences (NASDAQ:NERV) traded down 0.67% during mid-day trading on Wednesday, hitting $5.93. 43,059 shares of the company’s stock traded hands. Minerva Neurosciences has a 52-week low of $5.75 and a 52-week high of $6.38. The stock’s 50-day moving average is $5.99 and its 200-day moving average is $5.99. The company’s market cap is $108.4 million.

Minerva Neurosciences, Inc is a biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (NASDAQ:NERV), diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.